Chimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
Chimerix, Inc. (CMRX)
Last chimerix, inc. earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.chimerix.com/investor-relations
Company Research
Source: Yahoo! Finance
Research and Development : R&D expenses decreased to $15.6 million in Q4 2023 from $19.3 million in Q4 2022. General and Administrative Expenses : G&A expenses slightly decreased to $5.2 million in Q4 2023 from $5.3 million in Q4 2022. Full-Year Net Loss : For the full year, net loss stood at $82.1 million compared to net income of $172.2 million in 2022, primarily due to the gain on sale of TEMBEXA. Revenue : Annual revenues decreased to $0.3 million in 2023 from $33.8 million in 2022, following the TEMBEXA divestiture. Cash Position : Cash and equivalents totaled $204.5 million as of December 31, 2023. Warning! GuruFocus has detected 8 Warning Signs with CMRX. On February 29, 2024, Chimerix Inc ( NASDAQ:CMRX ) released its 8-K filing , detailing the financial results for the fourth quarter and the full year ended December 31, 2023, along with providing an operational update. The company, a biopharmaceutical entity engaged in the development of medications for cancer and
Show less
Read more
Impact Snapshot
Event Time:
CMRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CMRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CMRX alerts
High impacting Chimerix, Inc. news events
Weekly update
A roundup of the hottest topics
CMRX
News
- Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Chimerix GAAP EPS of -$0.25 [Seeking Alpha]Seeking Alpha
- Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update [Yahoo! Finance]Yahoo! Finance
- Chimerix Reports First Quarter 2024 Financial Results and Provides Operational UpdateGlobeNewswire
- Glioma Pipeline Landscape Report 2024: Comprehensive Market Insights on 180+ Companies and Respective 200+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
CMRX
Earnings
- 5/1/24 - Miss
CMRX
Sec Filings
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/26/24 - Form DEFA14A
- CMRX's page on the SEC website